Cargando…

High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients

The use of high-dose of intravenous immunoglobulins (IVIGs) as immunomodulators for the treatment of COVID-19–affected individuals has shown promising results. IVIG reduced inflammation in these patients, who progressively restored respiratory function. However, little is known about how they may mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez de la Concepción, María Luisa, Ainsua-Enrich, Erola, Reynaga, Esteban, Ávila-Nieto, Carlos, Santos, Jose Ramón, Roure, Silvia, Mateu, Lourdes, Paredes, Roger, Puig, Jordi, Jimenez, Juan Manuel, Izquierdo-Useros, Nuria, Clotet, Bonaventura, Pedro-Botet, María Luisa, Carrillo, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Life Science Alliance LLC 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321664/ https://www.ncbi.nlm.nih.gov/pubmed/34321327 http://dx.doi.org/10.26508/lsa.202001009

Ejemplares similares

Outcome of hospitalized patients with COVID-19 pneumonia treated with high-dose immunoglobulin therapy in a prospective case series
por: Reynaga, Esteban, et al.
Publicado: (2021)

Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
por: Pradenas, Edwards, et al.
Publicado: (2021)

Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals
por: Ainsua-Enrich, Erola, et al.
Publicado: (2022)

Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity
por: Carrillo, Jorge, et al.
Publicado: (2021)

Correlation between Clinical and Immunological Variables and Humoral Response to SARS-CoV-2 Vaccination in Adult Patients with Antibody Deficiency Disorders
por: Bracke, Carmen, et al.
Publicado: (2022)

Pigs are not susceptible to SARS‐CoV‐2 infection but are a model for viral immunogenicity studies
por: Vergara‐Alert, Júlia, et al.
Publicado: (2020)

SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity
por: Trinité, Benjamin, et al.
Publicado: (2021)

SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus
por: Muñoz-Basagoiti, Jordana, et al.
Publicado: (2021)

Prostaglandin E(2) Prevents Hyperosmolar-Induced Human Mast Cell Activation through Prostanoid Receptors EP(2) and EP(4)
por: Torres-Atencio, Ivonne, et al.
Publicado: (2014)

Myo1f, an Unconventional Long-Tailed Myosin, Is a New Partner for the Adaptor 3BP2 Involved in Mast Cell Migration
por: Navinés-Ferrer, Arnau, et al.
Publicado: (2019)

Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster
por: Brustolin, Marco, et al.
Publicado: (2021)

The infectious synapse formed between mature dendritic cells and CD4(+) T cells is independent of the presence of the HIV-1 envelope glycoprotein
por: Rodriguez-Plata, Maria T, et al.
Publicado: (2013)

Disseminated tuberculosis and diagnosis delay during the COVID-19 era in a Western European country: a case series analysis
por: Roure, Sílvia, et al.
Publicado: (2023)

Corrigendum: Disseminated tuberculosis and diagnosis delay during the COVID-19 era in a Western European country: a case series analysis
por: Roure, Sílvia, et al.
Publicado: (2023)

IRF4-dependent dendritic cells regulate CD8(+) T cell differentiation and memory responses in influenza infection
por: Ainsua-Enrich, Erola, et al.
Publicado: (2019)

Detection of SARS-CoV-2 in a cat owned by a COVID-19−affected patient in Spain
por: Segalés, Joaquim, et al.
Publicado: (2020)

Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen
por: Rodon, Jordi, et al.
Publicado: (2021)

Syphilis vaccine: challenges, controversies and opportunities
por: Ávila-Nieto, Carlos, et al.
Publicado: (2023)

Epidemiological, clinical, diagnostic and economic features of an immigrant population of chronic schistosomiasis sufferers with long-term residence in a non-endemic country (North Metropolitan area of Barcelona, 2002-2016)
por: Roure, Sílvia, et al.
Publicado: (2017)

Long-term cigarette smoke exposure dysregulates pulmonary T cell response and IFN-γ protection to influenza virus in mouse
por: Wu, Wenxin, et al.
Publicado: (2021)

Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif
por: Molinos-Albert, Luis M., et al.
Publicado: (2017)

Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia
por: Batule, Sol, et al.
Publicado: (2022)

HIV-1 trans-Infection Mediated by DCs: The Tip of the Iceberg of Cell-to-Cell Viral Transmission
por: Perez-Zsolt, Daniel, et al.
Publicado: (2021)

Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection
por: Pradenas, Edwards, et al.
Publicado: (2022)

A simple new screening tool for diagnosing imported schistosomiasis
por: Roure, Silvia, et al.
Publicado: (2022)

Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial
por: Revollo, Boris, et al.
Publicado: (2021)

HIV transfer between CD4 T cells does not require LFA-1 binding to ICAM-1 and is governed by the interaction of HIV envelope glycoprotein with CD4
por: Puigdomènech, Isabel, et al.
Publicado: (2008)

Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice
por: Vidal, Enric, et al.
Publicado: (2021)

Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth
por: Serrano‐Candelas, Eva, et al.
Publicado: (2018)

Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals
por: Pradenas, Edwards, et al.
Publicado: (2022)

Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report
por: Massanella, Marta, et al.
Publicado: (2021)

Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities
por: Trigueros, Macedonia, et al.
Publicado: (2022)

Siglec-1 Is a Novel Dendritic Cell Receptor That Mediates HIV-1 Trans-Infection Through Recognition of Viral Membrane Gangliosides
por: Izquierdo-Useros, Nuria, et al.
Publicado: (2012)

Agreement and differential use of laboratory methods for the detection and quantification of SARS-CoV-2 in experimentally infected animals
por: Usai, Carla, et al.
Publicado: (2022)

Gp120/CD4 Blocking Antibodies Are Frequently Elicited in ART-Naïve Chronically HIV-1 Infected Individuals
por: Carrillo, Jorge, et al.
Publicado: (2015)

First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain
por: Fernández-Bastit, Leira, et al.
Publicado: (2021)

Susceptibility of Domestic Goat (Capra aegagrus hircus) to Experimental Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.351/Beta Variant
por: Fernández-Bastit, Leira, et al.
Publicado: (2022)

Randomised Study to Assess the Efficacy and Safety of Once-Daily Etravirine-Based Regimen as a Switching Strategy in HIV-Infected Patients Receiving a Protease Inhibitor–Containing Regimen. Etraswitch Study
por: Echeverría, Patricia, et al.
Publicado: (2014)

Stable HIV-1 integrase diversity during initial HIV-1 RNA Decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy
por: Noguera-Julian, Marc, et al.
Publicado: (2013)

Nonhuman TRIM5 Variants Enhance Recognition of HIV-1-Infected Cells by CD8(+) T Cells
por: Jimenez-Moyano, Esther, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2mlt5d0dffuaotv7dj9jvf5efd